文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

巴基斯坦与阿富汗2型疫苗衍生脊髓灰质炎病毒暴发传播建模及COVID-19背景下防控策略

Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
PubMed 文献 · Vaccine · 2021-09-25

研究使用随机、地理结构化的数学模型模拟巴基斯坦和阿富汗2019年7月起cVDPV2暴发传播,模型分别捕捉黏膜和体液免疫并允许OPV2 revert。结果显示无疫苗接种时cVDPV2将广泛传播至2020年,早期且地理范围更大的接种响应可显著减少传播和病例负担,所提策略可在2021年2月前停止暴发且reverted Sabin-2传播风险低。

要点

  • 无疫苗接种情况下cVDPV2感染将广泛传播至2020年。
  • 早期且地理范围更大的疫苗接种响应能更有效减少传播和病例负担。
  • 所提疫苗接种策略可在2021年2月前停止cVDPV2暴发。

核心结论

  • 针对cVDPV2的暴发响应疫苗接种活动在COVID-19大流行期间将面临挑战,但一旦可行必须紧急实施以阻断cVDPV2传播。

研究设计与样本

  • 研究建立随机、地理结构化的cVDPV2传播数学模型,分别捕捉黏膜免疫和体液免疫,并允许接种OPV2后病毒revert为cVDPV2。
  • 模型纳入疫苗接种覆盖率、人群免疫和人口流动的地理异质性,并使用迭代粒子滤波拟合2010年1月至2016年4月及2019年7月至2020年3月巴基斯坦和阿富汗历史cVDPV2病例。

主要发现

  • 最佳拟合模型模拟的cVDPV2月发病率与观察病例在时空上总体一致。
  • 模型预测在无任何疫苗接种活动的情况下,cVDPV2感染将大幅传播并在2020年全年广泛传播。
  • 疫苗接种响应被预测可大幅减少传播和病例负担,且更早响应和地理范围更大的响应影响更大。
  • reverted Sabin-2播种风险在OPV2目标地区最高,但后续传播在无响应或延迟响应地区最大。
  • 所提疫苗接种策略显示可在2021年2月前停止cVDPV2暴发,且reverted Sabin-2传播风险低。

临床怎么用

  • 在COVID-19大流行期间应认识到cVDPV2暴发响应疫苗接种活动的挑战性,但一旦可行需紧急实施以阻断传播。
  • 接种响应应尽早启动并覆盖更大地理范围,以更有效减少cVDPV2传播和病例负担。
  • 需关注无响应或延迟响应地区,因其reverted Sabin-2后续传播风险最大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since July 2019, Pakistan and Afghanistan have been facing an outbreak of serotype-2 circulating vaccine derived poliovirus (cVDPV2) in addition to continued transmission of serotype-1 wild poliovirus (WPV1) and SARS-CoV-2 in 2020. Understanding the risks of cVDPV2 transmission due to pause of global vaccination efforts and the impact of potential vaccination response strategies in the current context of COVID-19 mitigation measures is critical. METHODS: We developed a stochastic, geographically structured mathematical model of cVDPV2 transmission which captures both mucosal and humoral immunity separately and allows for reversion of serotype-2 oral polio vaccine (OPV2) virus to cVDPV2 following vaccine administration. The model includes geographic heterogeneities in vaccination coverage, population immunity and population movement. The model was fitted to historic cVDPV2 cases in Pakistan and Afghanistan between January 2010-April 2016 and July 2019-March 2020 using iterated particle filtering. The model was used to simulate spread of cVDPV2 infection from July 2019 to explore impact of various proposed vaccination responses on stopping transmission and risk of spread of reverted Sabin-2 under varying assumptions of impacts from COVID-19 lockdown measures on movement patterns as well as declines in vaccination coverage. RESULTS: Simulated monthly incidence of cVDPV2 from the best-fit model demonstrated general spatio-temporal alignment with observed cVDPV2 cases. The model predicted substantial spread of cVDPV2 infection, with widespread transmission through 2020 in the absence of any vaccination activities. Vaccination responses were predicted to substantially reduce transmission and case burden, with a greater impact from earlier responses and those with larger geographic scope. While the greatest risk of seeding reverted Sabin-2 was predicted in areas targeted with OPV2, subsequent spread was greatest in areas with no or delayed response. The proposed vaccination strategy demonstrated ability to stop the cVDPV2 outbreak (with low risk of reverted Sabin-2 spread) by February 2021. CONCLUSION: Outbreak response vaccination campaigns against cVDPV2 will be challenging throughout the COVID-19 pandemic but must be implemented urgently when feasible to stop transmission of cVDPV2.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Molodecky NA, Jafari H, Safdar RM, et al. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic. Vaccine. 2021. PMID: 34629206. doi:10.1016/j.vaccine.2021.09.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。